Impact of In-Hospital Acquired Thrombocytopenia in Patients Undergoing Primary Angioplasty for Acute Myocardial Infarction
- 15 August 2005
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 96 (4) , 474-481
- https://doi.org/10.1016/j.amjcard.2005.04.005
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Thrombocytopenia Caused by Abciximab or Tirofiban and Its Association With Clinical Outcome in Patients Undergoing Coronary StentingCirculation, 2004
- Comparison of Angioplasty with Stenting, with or without Abciximab, in Acute Myocardial InfarctionNew England Journal of Medicine, 2002
- Cost-Effectiveness of Coronary Stenting in Acute Myocardial InfarctionCirculation, 2001
- Simvastatin‐induced thrombocytopeniaAmerican Journal of Hematology, 2001
- Thrombocytopenia complicating treatment with intravenous glycoprotein IIb/IIIa receptor inhibitors: A pooled analysisAmerican Heart Journal, 2000
- Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularizationJournal of the American College of Cardiology, 1998
- Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary RevascularizationNew England Journal of Medicine, 1997
- Clinical importance of thrombocytopenia occurring in the hospital phase after administration of thrombolytic therapy for acute myocardial infarctionJournal of the American College of Cardiology, 1994
- Hemorrhagic Events during Therapy with Recombinant Tissue-Type Plasminogen Activator, Heparin, and Aspirin for Acute Myocardial InfarctionAnnals of Internal Medicine, 1991
- Heparin-Associated Thrombocytopenia: A Comparison of Three Heparin PreparationsNew England Journal of Medicine, 1980